Franklin, Tenn., Feb. 06, 2017 -- IASIS Healthcare® LLC (“IASIS”) today announced that it will provide an online Web simulcast of its fiscal first quarter 2017 conference call on Friday, February 10, 2017. The Company will release its results for the fiscal first year ended December 31, 2016, before the opening of the market on February 10th.
The live broadcast of IASIS’ conference call will begin at 11:00 a.m. Eastern Time on February 10th. The link to this event can be found at the Company’s website: www.iasishealthcare.com. In addition, an online replay will be available an hour after the call ends and will be available for 30 days. The online replay can also be found on the Company’s website.
About IASIS Healthcare
IASIS Healthcare is a healthcare services company that seeks to deliver high-quality, cost-effective healthcare through a broad and differentiated set of capabilities and assets that include acute care hospitals with related patient access points and a diversified managed care risk platform. With total annual revenue of approximately $3.3 billion, IASIS, headquartered in Franklin, Tennessee, owns and operates 17 acute care hospitals, one behavioral hospital and multiple other access points, including 139 physician clinics, multiple outpatient surgical units, imaging centers, and investments in urgent care centers and on-site employer-based clinics. Health Choice, the Company’s managed care risk platform, delivers services to more than 681,300 covered lives through its multiple health plans, accountable care networks and agreements to serve as a management services organization (“MSO”) with third party insurers. For more information on IASIS, please visit the Company’s Web site at www.iasishealthcare.com.
Investor Contact: John M. Doyle Chief Financial Officer (615) 844-2747


Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



